Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.
about
Changes in predominance and diversity of genomic subtypes of Bordetella pertussis isolated in the United States, 1935 to 1999Variation in Bordetella pertussis Susceptibility to Erythromycin and Virulence-Related Genotype Changes in China (1970-2014)Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic modelReemergence of pertussis in the highly vaccinated population of the Netherlands: observations on surveillance data.Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains.Comparative genomic profiling of Dutch clinical Bordetella pertussis isolates using DNA microarrays: identification of genes absent from epidemic strainsEstimating the duration of pertussis immunity using epidemiological signatures.Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cellsPolymorphism in the Bordetella pertussis virulence factors P.69/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolutionPolymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 yearsVariation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in FinlandImmunoglobulin A-mediated protection against Bordetella pertussis infection.Genetic Profile Variation in Vaccine Strains and Clinical Isolates of Bordetella pertussis Recovered from Iranian Patients.Antigenic divergence of Bordetella pertussis isolates in Taiwan.Multilocus sequence typing of Bordetella pertussis based on surface protein genes.Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis.Report of a pertussis outbreak in a low coverage booster vaccination group of otherwise healthy children in Italy.Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age.Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994Pertussis. A reemerging and an underreported infectious disease.Identification of pertussis-specific effector memory T cells in preschool childrenEffects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy modelsReference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profilesIncreasing incidence of pertussis in Brazil: a retrospective study using surveillance data.Lipopolysaccharide analogs improve efficacy of acellular pertussis vaccine and reduce type I hypersensitivity in mice.Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussisModelling the impact of extended vaccination strategies on the epidemiology of pertussisPertussis Epidemiology in Greece and Emerging Risk Groups during the Vaccination Era (1980-2008).Are vaccination programs and isolate polymorphism linked to pertussis re-emergence?Whooping cough dynamics in Chile (1932-2010): disease temporal fluctuations across a north-south gradient.Pertussis infection in fully vaccinated children in day-care centers, IsraelAdaptation of Bordetella pertussis to vaccination: a cause for its reemergence?Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresisImmunodominance in mouse and human CD4+ T-cell responses specific for the Bordetella pertussis virulence factor P.69 pertactin.Multilocus Sequence Analysis of Housekeeping Genes and Antigenic Determinant Genes in Bordetella pertussis Strains Isolated in Korea.Comparison of culture and real-time PCR for detection of Bordetella pertussis isolated from patients in Iran.Dynamic models for health economic assessments of pertussis vaccines: what goes around comes around....Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity.Immunogenicity and protective efficacy of recombinant iron superoxide dismutase protein from Bordetella pertussis in mice models.Virulence Factors Variation Among Bordetella Pertussis Isolates in Iran.
P2860
Q28366752-6FE7578F-DE6F-457D-9C24-4E68FABD6D85Q28548545-21557905-17B4-450F-B437-0EB877BD0243Q28748851-BE95FD62-66D8-49F3-815C-53ABDDAE0866Q30604001-7FE19D3C-F77C-4892-A5F5-BB67A3868B69Q30833407-58A894A9-4347-4525-ADBA-077FBFACC57EQ33347857-5F341515-D13A-4A43-9283-03BDE5298FD6Q33513972-41187E83-4AD3-4435-99E6-007AEC40705AQ33601872-E2AFACA7-0A9F-49FF-80F5-C024839A919AQ33750402-D5C57D82-9345-4952-9A52-F7699AF5F5CAQ33974293-5A564B47-9A0D-450A-8FE0-B569F0163599Q34001270-B431BCA9-EDB9-426A-B02A-588FA5FFC229Q34008531-5F59D840-7099-4A09-BA93-FA2017534AB6Q34099995-F7065703-B408-45C6-B347-6425D99C6F96Q34143806-A2DE3D4E-6D3B-45D5-8ADA-9FB0D4941738Q34196111-C3B370C2-22AA-4D32-9562-1FF848492349Q34197430-F6BA1ED1-3A37-481A-8C03-35061CB2D104Q34478923-298FC83E-219B-4C8D-9DF0-151BD3577048Q35082532-7B9E6D19-2CCC-4FDA-AF27-1FA2C3A6FAA8Q35155957-87AA29B8-2C63-4E1E-92D2-E3F34FE4662FQ35183514-F59E9457-7461-47A2-931B-AAA97E225834Q35548052-1B381BD2-7160-4728-8E73-74651C5C4D2BQ35690073-523D0DA0-D165-4DBB-93A1-F977762B25FDQ35715416-BC6D7682-391B-42FA-B891-B4BCCB24CE18Q35820060-31C057B0-6948-4CB1-B0BB-60302E25BD59Q35946895-061A65C5-14B3-4F15-8AB9-9CFF922573CEQ35964270-64434EB0-366D-4873-AD34-B5A140508B47Q36114501-BC988B23-3593-4A5A-812C-0A45590152EAQ36277476-22433459-A778-478E-A9AB-57BBC72F0E75Q36284571-D978A5FC-9A06-4EDA-83D7-CD86507F1AC5Q36416536-F1412E04-8B70-4154-A9E6-97DA1F0FE054Q37065024-9F3993E8-5B80-4F69-99DD-54A5AAA75920Q37075063-FC2549B2-7DEC-445E-B3D5-758047D922A1Q37075145-71B3DACF-B905-4EAC-875D-BA3A62A1144CQ37075449-54985D8F-50F1-44D1-A92C-16B1BEA5E321Q37155751-80468B75-5548-429E-BF16-930855A40BA3Q37492795-C7BC1169-C622-4C94-AA58-D3F50B48A68CQ38068468-26A3C6C0-42E1-4233-AD57-BFFF56AC6F3EQ38228975-34444043-F6F6-4B67-B897-5510A42B6926Q40497346-3549782D-4AF2-4454-9B70-819AF13CC3E8Q41114404-AD162C0E-0B9B-465C-83A7-59DBAB2ED647
P2860
Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pertussis in The Netherlands: ...... ation with whole-cell vaccine.
@en
Pertussis in The Netherlands: ...... ation with whole-cell vaccine.
@nl
type
label
Pertussis in The Netherlands: ...... ation with whole-cell vaccine.
@en
Pertussis in The Netherlands: ...... ation with whole-cell vaccine.
@nl
prefLabel
Pertussis in The Netherlands: ...... ation with whole-cell vaccine.
@en
Pertussis in The Netherlands: ...... ation with whole-cell vaccine.
@nl
P2093
P356
P1476
Pertussis in The Netherlands: ...... ation with whole-cell vaccine.
@en
P2093
Conyn-van Spaendonck MA
Schellekens JF
de Melker HE
van Wijngaarden JK
P2860
P304
P356
10.3201/EID0302.970211
P577
1997-04-01T00:00:00Z